Holen Sie sich die Stockscreener-App
33.80
0.22%
-0.115
Schlusskurs vom Vortag:
$33.92
Offen:
$34.14
24-Stunden-Volumen:
63,285
Relative Volume:
0.36
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.70%
1M Leistung:
-5.65%
6M Leistung:
+9.57%
1J Leistung:
+17.23%
1-Tages-Spanne:
$33.67
$34.34
1-Wochen-Bereich:
$33.67
$35.22
52-Wochen-Spanne:
$26.10
$38.68
Simplify Health Care Etf Stock (PINK) Company Profile
Firmenname
Simplify Health Care Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare PINK vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PINK
Simplify Health Care Etf
|
33.79 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
326.92 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
663.97 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
666.89 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
260.86 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
594.62 | 124.43B | 0 | 0 | 0 | 0.00 |
Simplify Health Care Etf Aktie (PINK) Neueste Nachrichten
Nidec Announces the Establishment of the Executive Responsibility Investigation Committee - ChartMill
Asahi Kasei Begins Installation of Containerized Alkaline-Water Electrolyzer at Finland’s First Commercial Hydrogen Refueling Station - ChartMill
Eli Lilly's Experimental Cancer Drug Cuts Recurrence Risk In Early-Stage Lung Cancer Patients - AOL.com
CreativeOne Wealth LLC Grows Stock Holdings in Simplify Barrier Income ETF $SBAR - Defense World
Why (PINK) Price Action Is Critical for Tactical Trading - Stock Traders Daily
What's Going On With Biohaven Stock On Monday? - Benzinga
Is Simplify Health Care ETF stock a top hedge fund pickPortfolio Gains Summary & Stepwise Trade Execution Plans - Naître et grandir
Nidec Announces the Disclosure of the Third-Party Committee’s Investigation Report and Our Company’s Response - ChartMill
Yubico Establishes Singapore as Third Global Headquarters Accelerating Asia Pacific Growth - ChartMill
Lenovo Unveils Adaptive AI PCs, Modular Concepts, and Lenovo Qira Rollout at MWC 2026 - ChartMill
Understanding Momentum Shifts in (PINK) - Stock Traders Daily
Asahi Kasei Strengthens Global Pharmaceutical Platform with the Acquisition of Aicuris - ChartMill
eDreams ODIGEO Grows Net Income Tenfold to €40.3 Million as Prime Reaches 7.8 Million Members - ChartMill
Asahi Kasei Pharma Strengthens Preclinical Pipeline Through Exclusive Global License Agreement with Alchemedicine for Novel Lead Compounds - ChartMill
How does Danaher Corporation’s stock stack up against other companies in the health care sector? - Bitget
How Is Danaher Corporation’s Stock Performance Compared to other Health Care Stocks? - inkl
Yubico Unveils “YubiNation Partners”: A New Era of Global Channel Partnership to Secure Digital Identities in the Age of AI - ChartMill
KDDIY INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving KDDI Corporation - ChartMill
Want To Simplify Investing? Buy These 2 ETFs And Let America Do The Work - Seeking Alpha
Lenovo Unlocks Data Potential with Next Generation of AI-Driven ThinkEdge Solutions - ChartMill
How well a cancer treatment works may depend on the time of day you get it - AOL.com
FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer - AOL.com
How AI is speeding up cancer research - AOL.com
Researchers repurpose existing lung cancer drug to fight ovarian tumors - AOL.com
Soleus Adds a Significant Number of Celcuity Shares - AOL.com
Rob Lowe Wants More People to Join Cancer Clinical Trials. Here’s Why - AOL.com
Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition - AOL.com
Warning: This Skyrocketing Stock Has a Hidden Risk - AOL.com
Ocular Therapeutix Drug Shows Promise In Eye Disorder, But Falls Short of Investor Hopes - AOL.com
Bolt Projects Holdings Announces Delisting From Nasdaq and SEC Deregistration - ChartMill
Lilly signs up to $1.93 billion deal with Repertoire for autoimmune therapies - AOL.com
IEEE Recognizes Asahi Kasei Microdevices’ Commercialization of Thin-Film Hall Elements as an IEEE Milestone - ChartMill
Alset AI Provides Update on Loan Transaction of up to $3 Million - 富途牛牛
CSL licenses Eli Lilly's clazakizumab to cut cardiac risk in end-stage kidney disease - AOL.com
Why Eli Lilly’s $1 Billion AI Bet Could Reshape Drug Discovery - AOL.com
Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases - ChartMill
1 Reason I'd Buy Eli Lilly Stock and Never Sell - AOL.com
Waystar Recognized as Inc. Best in Business for AI - GuruFocus
Waystar Recognized as Inc. Best in Business for AI – Company Announcement - Financial Times
Avoiding Lag: Real-Time Signals in (PINK) Movement - Stock Traders Daily
Will Simplify Health Care ETF stock justify high valuationJuly 2025 Institutional & Real-Time Volume Triggers - mfd.ru
Securities Fraud Investigation Into BYD Company Limited (BYDDF) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - ChartMill
Lenovo Group: Third Quarter Financial Results 2025/26 - ChartMill
KDDI CORPORATION INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - ChartMill
Securities Fraud Investigation Into KDDI Corporation (KDDIY) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - ChartMill
Rosen Law Firm Encourages KDDI Corporation Investors to Inquire About Securities Class Action Investigation – KDDIY - ChartMill
Eli Lilly Is Partnering with Gene-Editing Start-up Seamless Therapeutics. Here's What Investors Need to Know. - AOL.com
Eli Lilly Shares Surge on Weight-Loss Drug Momentum. Is It Time to Buy the Stock? - AOL.com
VLVLY Investors Have Opportunity to Join AB Volvo Fraud Investigation with the Schall Law Firm - ChartMill
Eli Lilly Just Delivered Fantastic News to Shareholders - AOL.com
Crawford United Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crawford United CorporationCRAWA - ChartMill
Finanzdaten der Simplify Health Care Etf-Aktie (PINK)
Es liegen keine Finanzdaten für Simplify Health Care Etf (PINK) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):